You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Primary CNS lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-hodgkin Lymphoma Trial (Methotrexate, Rituximab (where available), Ibrutinib)

Not yet recruiting
  • Non-hodgkin Lymphoma
  • (no location specified)
Aug 11, 2023

Primary CNS Lymphoma Trial in London (CD19CAR T-cells)

Recruiting
  • Primary CNS Lymphoma
  • CD19CAR T-cells
  • London, United Kingdom
    University College London Hospital
Jun 13, 2022

Primary CNS Lymphoma Trial in San Francisco (Hyperpolarized pyruvate (13C), Magnetic resonance imaging (MRI))

Recruiting
  • Primary CNS Lymphoma
  • Hyperpolarized pyruvate (13C)
  • Magnetic resonance imaging (MRI)
  • San Francisco, California
    University of California, San Francisco
Apr 22, 2022

Primary CNS Lymphoma Trial in Stuttgart (Venetoclax, Obinutuzumab)

Terminated
  • Primary CNS Lymphoma
  • Stuttgart, Baden-Württemberg, Germany
    Klinikum Stuttgart
Jan 18, 2022

CNS Lymphoma Trial in Petah Tikva (Imbruvica)

Recruiting
  • Central Nervous System Lymphoma
  • Petah Tikva, Israel
    Hematology Institute
May 9, 2022

Primary CNS Lymphoma (PCNSL) Trial in Zhengzhou (HD-MTX-Ara-C regimen, FTD regimen)

Completed
  • Primary CNS Lymphoma (PCNSL)
  • HD-MTX-Ara-C regimen
  • FTD regimen
  • Zhengzhou, Henan, China
    Oncology Department of The First Affiliated Hospital of Zhengzho
Mar 2, 2022

Primary CNS Lymphoma Trial in Moscow (Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide)

Recruiting
  • Primary CNS Lymphoma
  • Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide
  • Moscow, Russian Federation
    Nathional Medical Research Center for Hematology
Jun 16, 2022

Primary CNS Lymphoma Trial in Stuttgart (Experimental Treatment: one course Rituximab/HD-Methotrexate, two courses of MATRix,

Recruiting
  • Primary Central Nervous System Lymphoma
  • Experimental Treatment: one course Rituximab/HD-Methotrexate, two courses of MATRix
  • Control intervention: four courses of MATRix
  • Stuttgart, Baden-Württemberg, Germany
    Klinikum Stuttgart
Feb 15, 2022

Primary Mediastinal Large B-cell Lymphoma With CNS Involvement

Recruiting
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • Milan, Italy
      Ospedale San Raffaele
    Aug 29, 2023

    CNS Involvement in Primary Mediastinal Large B-Cell Lymphoma

    Active, not recruiting
    • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • DISEASE
    • (no location specified)
    May 4, 2023

    Primary CNS Lymphoma, PCNSL, Non Hodgkin Lymphoma Trial in Guandong, Guangzhou (Methotrexate, Ibrutinib, Temozolomide)

    Recruiting
    • Primary Central Nervous System Lymphoma
    • +2 more
    • Guandong, Guangdong, China
    • +2 more
    Apr 6, 2022

    Lymphoma, Lymphoma Cns Trial in Boston (Fludarabine, Cyclophosphamide, Axicabtagene Ciloleucel)

    Recruiting
    • Lymphoma
    • Lymphoma Cns
    • Boston, Massachusetts
    • +1 more
    Jan 3, 2023

    Primary CNS Lymphoma Trial (Penpulimab)

    Not yet recruiting
    • Primary Central Nervous System Lymphoma
    • (no location specified)
    Apr 20, 2022

    CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma Trial in Basking Ridge, Commack, New York (Rituximab, Methotrexate,

    Active, not recruiting
    • CNS Lymphoma
    • +2 more
    • Rituximab, Methotrexate, Vincristine, Procarbazine, PBPCs collection, Busulfan, Thiotepa, and Cyclophosphamide
    • Basking Ridge, New Jersey
    • +2 more
    Jan 27, 2023

    CNS Lymphoma Trial in Essen ([90Y]Y-PentixaTher)

    Recruiting
    • CNS Lymphoma
    • Essen, Germany
      University Hospital Essen
    Nov 16, 2023

    Primary CNS Lymphoma, Secondary CNS Lymphoma, Relapsed Cancer Trial in Miami (drug, procedure, radiation)

    Not yet recruiting
    • Primary Central Nervous System Lymphoma
    • +3 more
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc.
    Dec 23, 2022

    Refractory and Relapsed Primary CNS Lymphoma, PCNSL, Non Hodgkin Lymphoma Trial in Guangzhou (Orelabrutinib, Thiotepa)

    Not yet recruiting
    • Refractory and Relapsed Primary CNS Lymphoma
    • +2 more
    • Guangzhou, Guangdong, China
      Department of Medical Oncology, Sun Yat-sen University Cancer Ce
    Aug 19, 2021

    Primary CNS Lymphoma Trial in Seoul (Rituximab, lenalidomide)

    Recruiting
    • Primary CNS Lymphoma
    • Rituximab, lenalidomide
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Feb 4, 2022

    CNS Lymphoma Trial (68Ga-PTF)

    Recruiting
    • CNS Lymphoma
    • Aalborg, Denmark
    • +1 more
    Jan 17, 2023

    CNS Lymphoma, Primary CNS Lymphoma, Secondary CNS Lymphoma Trial in San Francisco (Tafasitamab, Lenalidomide)

    Recruiting
    • CNS Lymphoma
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Aug 10, 2022

    Primary CNS Lymphoma Trial in Milan (Lumbar puncture)

    Recruiting
    • Primary CNS Lymphoma
    • Lumbar puncture
    • Milan, Italy/Lombardy, Italy
      IRCCS Ospedale San Raffaele
    Sep 5, 2021

    Lymphoma, Non-Hodgkin, HIV Trial in New Orleans (Methotrexate, Leucovorin calcium, Zidovudine)

    Terminated
    • Lymphoma, Non-Hodgkin
    • HIV Infections
    • New Orleans, Louisiana
      Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU
    Oct 27, 2021

    Primary CNS Lymphoma Trial in Paris (PET-MRI)

    Not yet recruiting
    • Primary Central Nervous System Lymphoma
    • Paris, France
      Hôpital Pitié Salpêtrière
    May 20, 2022

    CNS Lymphoma Trial in Chapel Hill, Winston-Salem (Acalabrutinib, Isavuconazole)

    Recruiting
    • Central Nervous System Lymphoma
    • Chapel Hill, North Carolina
    • +1 more
    Mar 24, 2022

    CNS Lymphoma Trial in Worldwide (GB5121)

    Recruiting
    • CNS Lymphoma
    • Phoenix, Arizona
    • +5 more
    Jul 26, 2022